Embryonic stem cells as sources of donor-independent platelets

2Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

The creation of a donor-independent source of platelets has been challenging; however, recent advances show growing promise for alternative platelet sources. Pluripotent stem cells have the capacity to differentiate into mature megakaryocytes with the ability to produce functional platelets. In this issue of JCI, Noh et al. provide a proof-of-principle demonstration that embryonic stem cells can be used to produce platelets on a clinical scale by controlling the level of the transcription factor GATA1. This study emphasizes the importance of precise regulation of gene expression for regenerative medicine applications.

Cite

CITATION STYLE

APA

Canver, M. C., Bauer, D. E., & Orkin, S. H. (2015, June 1). Embryonic stem cells as sources of donor-independent platelets. Journal of Clinical Investigation. American Society for Clinical Investigation. https://doi.org/10.1172/JCI82348

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free